The PKG™ system provides continuous, objective, ambulatory assessment of movement disorder symptoms, such as tremor, dyskinesia and bradykinesia during activities of daily living and in the patient's home environment.
Consisting of an interactive watch that collects movement data, proprietary algorithms and a detailed report, the PKG™ system also correlates the frequency and severity of symptoms with respect to consumption of Parkinson's medication.
30 November 2017Read More
GKC has received notification of issuance by the US patent office of a patent covering its key product the Personal KinetiGraph™ (PKG™).
This US patent, number 9,826,921, has now been granted to GKC,…
23 November 2017Read More
The October edition of the Dutch Parkinson Magazine, published by the Dutch Parkinson's disease Association, highlighted an interview with Anne van der Plas, neurologist at the Alrijne hospital in the…
05 October 2017Read More
GKC announced today that it has appointed John Schellhorn as its new President and CEO. Schellhorn will also be joining the company’s Board of Directors.
Schellhorn joins GKC with a proven track reco…